American Financial Statements From 2010 to 2025
| AONC Stock | 12.00 0.00 0.00% |
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.2789 | Revenue |
American Oncology Total Revenue |
|
Check American Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among American Oncology's main balance sheet or income statement drivers, such as Net Income Applicable To Common Shares of 2.1 M, Income Tax Expense of 2.4 M or Tax Provision of 2.6 M, as well as many indicators such as Price To Sales Ratio of 0.0375, Dividend Yield of 0.0 or PTB Ratio of 3.51. American financial statements analysis is a perfect complement when working with American Oncology Valuation or Volatility modules.
American | Select Account or Indicator | Build AI portfolio with American Stock |
American Oncology Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Oncology Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Oncology Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Fundamental Market Drivers
About American Oncology Financial Statements
American Oncology stakeholders use historical fundamental indicators, such as American Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although American Oncology investors may analyze each financial statement separately, they are all interrelated. For example, changes in American Oncology's assets and liabilities are reflected in the revenues and expenses on American Oncology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in American Oncology Network. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 1.8 B | 1.3 B | |
| Cost Of Revenue | 1.6 B | 1.2 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.08 | 0.06 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 128.27 | 134.68 | |
| Ebit Per Revenue | (0.01) | (0.01) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether American Oncology Network is a strong investment it is important to analyze American Oncology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact American Oncology's future performance. For an informed investment choice regarding American Stock, refer to the following important reports:Check out the analysis of American Oncology Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Oncology. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.89) | Revenue Per Share | Quarterly Revenue Growth 0.514 | Return On Assets | Return On Equity |
The market value of American Oncology Network is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Oncology's value that differs from its market value or its book value, called intrinsic value, which is American Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Oncology's market value can be influenced by many factors that don't directly affect American Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between American Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.